Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Nuclear Medicine

Free Subscription 05.01.2026 1 Am J Psychiatry 5 Ann Nucl Med 26 Clin Nucl Med 2 Hum Brain Mapp 4 J Nucl Cardiol 14 J Nucl Med 1 Neurologia (Engl Ed) 3 Nucl Med Commun 2 PLoS One 1 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Psychiatry

1. NAPLES AJ, Yang Y, Gravel P, Toyonaga T, et al
   Imaging Metabotropic Glutamate Receptor 5 and Excitatory Neural Activity in Autism.
   Am J Psychiatry. 2026;183:58-69.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

2. MOCHIZUKI N, Hara T, Masubuchi M, Furuya K, et al
   Software-based de-filtering restores quantitative accuracy in Clarity2D-enhanced whole-body bone scintigraphy.
   Ann Nucl Med. 2025 Dec 29. doi: 10.1007/s12149-025-02145.
   PubMed         Abstract available
   
   
3. SALIMI M, Vadipour P, Khosravi A, Salimi B, et al
   Diagnostic accuracy of (1)(8)F-FDG PET/CT radiomics for non-invasive prediction of PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
   Ann Nucl Med. 2025 Dec 29. doi: 10.1007/s12149-025-02148.
   PubMed         Abstract available
   
   
4. JEONG J, Park BW, Kim YK, Lim CH, et al
   Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism.
   Ann Nucl Med. 2025 Dec 24. doi: 10.1007/s12149-025-02147.
   PubMed        
   
   
5. BADARCHIN M, Otomi Y, Shinya T, Otsuka H, et al
   Comparative evaluation of CortexID and VIZCalc software in brain amyloid PET: a retrospective study of 116 cases.
   Ann Nucl Med. 2025 Dec 20. doi: 10.1007/s12149-025-02146.
   PubMed         Abstract available
   
   
6. MA H, Xia L, Liu D, Wang S, et al
   (18)F-FDG PET/CT manifestations of extra-adrenal retroperitoneal ganglioneuroma: a retrospective study of 21 cases.
   Ann Nucl Med. 2025 Dec 20. doi: 10.1007/s12149-025-02149.
   PubMed        
   
   

   
   Clin Nucl Med

7. JIAO B, Ma X, Dong A, Lin C, et al
   FDG PET/CT in a Case of Primary Multifocal Intraparenchymal Rosai-Dorfman Disease of the Brain.
   Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006257.
   PubMed         Abstract available
   
   
8. SALEM AE, Krebs S, Morton K
   Genioglossus Muscle Uptake on 18F-FDG PET/CT, Secondary to Hypoglossal Nerve Stimulation: A Potential Oncologic Imaging Pitfall.
   Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006286.
   PubMed         Abstract available
   
   
9. KRIEGER K, Scherr BF, Gelpke H, Bosma IJ, et al
   Pulmonary Air Leak SPECT/CT in a Mechanically Ventilated Intensive Care Patient.
   Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006281.
   PubMed         Abstract available
   
   
10. ZHAO X, Guo X, Liang H, Zhao G, et al
    "Diffuse Hot Pleura" in a Case of Primary Undifferentiated Small Round Cell Sarcoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006246.
    PubMed         Abstract available
    
    
11. WANG S, Zhao Y, Cui Y, Li Y, et al
    18F-FAPI-42 PET/CT Finding in a Patient With Pancreatic Ductal Adenocarcinoma Encapsulated by Immunoglobulin G4-related Autoimmune Pancreatitis Located at the Pancreatic Body.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006216.
    PubMed         Abstract available
    
    
12. QUAK E, Catroux A, Lasne-Cardon A, Ciappuccini R, et al
    False-Positive Skin Uptake on 18F-Choline PET/CT Related to an Inflammatory Epidermoid Cyst in a Patient With Parathyroid Adenoma.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006291.
    PubMed         Abstract available
    
    
13. ADANIYA S, Saginoya T, Tomura N, Goto H, et al
    11C-Methionine PET for Detecting Solitary Fibrous Tumor Metastases: 2 Cases With Negative FDG-PET.
    Clin Nucl Med. 2025 Dec 19. doi: 10.1097/RLU.0000000000006070.
    PubMed         Abstract available
    
    
14. MOHSENY A, Mumtaz M, Cangut B, Ghesani N, et al
    Strong PSMA Expression by a Pituitary Macroadenoma on PSMA PET/CT.
    Clin Nucl Med. 2025 Dec 19. doi: 10.1097/RLU.0000000000006279.
    PubMed         Abstract available
    
    
15. YAO X, Wei L, Lei X, Wang Z, et al
    18F-FDG PET/CT Manifestation of Unilateral Breast Involvement in a Male Patient With T-Cell Acute Lymphoblastic Leukemia.
    Clin Nucl Med. 2025 Dec 19. doi: 10.1097/RLU.0000000000006272.
    PubMed         Abstract available
    
    
16. ELAHIFARD H, Samadi MH, Saberifar M, Taheri F, et al
    Diffuse Intense Pancreatic Uptake on 99mTc-HYNIC-TOC SPECT/CT in a Rare Case of Diffuse Pancreatic Neuroendocrine Tumor.
    Clin Nucl Med. 2025 Dec 18. doi: 10.1097/RLU.0000000000006288.
    PubMed         Abstract available
    
    
17. WAKANKAR R, Dharmashaktu Y, Puri G, Chumber S, et al
    Three Different Etiologies in Three Similar Looking Intrathyroidal Nodules: Role of Tc-99m SestaMIBI Scintigraphy and SPECT-CT in a Patient With Primary Hyperparathyroidism.
    Clin Nucl Med. 2025 Dec 17. doi: 10.1097/RLU.0000000000006142.
    PubMed         Abstract available
    
    
18. KUMAR SA, S S, Goyal H, Madivanane V, et al
    "Metabolic Superscan" Pattern in a Case of Secondary Hyperparathyroidism With Parathyroid Hyperplasia Detected on 68Ga-Trivehexin PET/CT.
    Clin Nucl Med. 2025 Dec 16. doi: 10.1097/RLU.0000000000006255.
    PubMed         Abstract available
    
    
19. MIRSHAHVALAD SA, Alghamdi A, Chavoshi M, Felder C, et al
    Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis.
    Clin Nucl Med. 2025 Dec 30. doi: 10.1097/RLU.0000000000006270.
    PubMed         Abstract available
    
    
20. THAKUR S, Raju S, Rajguru R, Chowhan AK, et al
    Dual-Tracer PET/CT in Erysipelas-like Cutaneous Metastases From Salivary Duct Adenocarcinoma: FAPI Illuminates What FDG Missed.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006253.
    PubMed         Abstract available
    
    
21. ARCA B, Isik EG, Denizmen Zorba D, Barburoglu M, et al
    Focal 68Ga-Trivehexin Uptake in a Normal Pituitary Gland: Expanding the Spectrum of alphavbeta6-integrin PET Findings.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006266.
    PubMed         Abstract available
    
    
22. EL YAAGOUBI Y, Prunier-Aesch C, Couchot M, Philippe L, et al
    De Quervain Tenosynovitis Detected by Blood Pool SPECT/CT Using New 3D-ring CZT System.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006290.
    PubMed         Abstract available
    
    
23. KHOO ACH, Chew GK
    The Use of FAPi PET-CT in Recurrent Malignant Uterine PEComa.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006121.
    PubMed         Abstract available
    
    
24. LI Y, Wang K, Zhang Z, Chen Y, et al
    Vaginal Mucosal Melanoma on 18F-FDG and 68Ga-FAPI-04 PET/CT.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006262.
    PubMed         Abstract available
    
    
25. WANG X, Lv Y, Qin C, Lan X, et al
    Isolated Splenic Myofibroma in a Child on 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Dec 30. doi: 10.1097/RLU.0000000000006213.
    PubMed         Abstract available
    
    
26. SCHWEIGHOFER N, Filipic M, Varda NM, Cuderman A, et al
    18F-FDG PET/CT in Rhabdomyosarcoma of the Prostate in an Infant.
    Clin Nucl Med. 2025 Dec 30. doi: 10.1097/RLU.0000000000006248.
    PubMed         Abstract available
    
    
27. QIN C, Lv Y, Gai Y, Hu F, et al
    First-in-Human Study of 68Ga-FAP-75 PET Imaging of Cancer-associated Fibroblasts: Biodistribution, Radiation Dosimetry, and Tumor Delineation.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006157.
    PubMed         Abstract available
    
    
28. WEISSENSEE A, Bregenzer CM, Viscione M, Mingels C, et al
    Imaging of Small Lung Nodules on Modern SAFOV and LAFOV PET in Combination With Data-driven Motion Correction: Implications for Current Practice.
    Clin Nucl Med. 2025 Dec 26. doi: 10.1097/RLU.0000000000006278.
    PubMed         Abstract available
    
    
29. KUCUKER C, Kaya G, Ergun EL, Ugur O, et al
    Imaging Discordance Between [(6)(8)Ga]-PSMA PET and [(1)(7)(7)Lu]-PSMA SPECT in mCRPC.
    Clin Nucl Med. 2025 Dec 30. doi: 10.1097/RLU.0000000000006293.
    PubMed         Abstract available
    
    
30. LIANG M, Jia C, Huang Z, Zhang T, et al
    18F-FDG, 18F-FP-CIT, and 18F-Florzolotau PET Imaging in Progressive Supranuclear Palsy: Region-Specific Correlations Between Glucose Metabolism, Dopaminergic Function, and Tau Pathology.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006254.
    PubMed         Abstract available
    
    
31. GUO X, Liu J, Ma H, Ma X, et al
    Al18F-NOTA-HER2-BCH Versus 18F-FDG PET/CT for Detecting Bone Metastases: Sensitivity and Quantitative Comparison.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006249.
    PubMed         Abstract available
    
    
32. KRIEGER K, Heil A, Gelpke H, Zehnder A, et al
    Localization of Persistent Air Leaks Using Technetium-99m Technegas SPECT/CT.
    Clin Nucl Med. 2025 Nov 27. doi: 10.1097/RLU.0000000000006247.
    PubMed         Abstract available
    
    

    
    Hum Brain Mapp

33. NEUMANN D, Razlighi QR, Stern Y, Devanand DP, et al
    Disrupted Energetic and Entropic Landscape in Individuals With Mild Cognitive Impairment: Insights From Network Control Theory.
    Hum Brain Mapp. 2025;46:e70427.
    PubMed         Abstract available
    
    
34. PECSOK MK, Shafiei G, Atkins A, Calkins ME, et al
    Characterizing Spatial Associations Between GluCEST MRI and Neurotransmitter Receptor Density in the Human Cortex.
    Hum Brain Mapp. 2025;46:e70442.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

35. LIGA R, Filidei E, Runza G, Gimelli A, et al
    Accuracy of myocardial perfusion imaging in older patients: Insights from a sub-analysis of the AMICO registry.
    J Nucl Cardiol. 2025;54:102530.
    PubMed         Abstract available
    
    
36. ALWAN M, El Yaman A, Sayed A, Shaikh A, et al
    Cardiac nuclear imaging workforce: Trends from Medicare Part B (2013-2022).
    J Nucl Cardiol. 2025;54:102472.
    PubMed         Abstract available
    
    
37. TORRES ORDONEZ A, Akincioglu C, Soman P, Kanitsorphan C, et al
    Diagnostic Discordance between Planar and SPECT Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    J Nucl Cardiol. 2025 Dec 18:102618. doi: 10.1016/j.nuclcard.2025.102618.
    PubMed         Abstract available
    
    
38. 
    Clinical Indications for PET Myocardial Perfusion Imaging and Myocardial Blood Flow Quantification: An American Society of Nuclear Cardiology (ASNC) Position Statement.
    J Nucl Cardiol. 2025 Dec 31:102619. doi: 10.1016/j.nuclcard.2025.102619.
    PubMed        
    
    

    
    J Nucl Med

39. VAN BINSBERGEN WH, de Jongh J, Yaqub M, van der Pas S, et al
    Macrophage-Targeted [(11)C]DPA-713 PET/CT Imaging for Early Therapeutic Evaluation of Anti-Tumor Necrosis Factor Treatment in Rheumatoid Arthritis.
    J Nucl Med. 2025 Dec 30:jnumed.125.270289. doi: 10.2967/jnumed.125.270289.
    PubMed         Abstract available
    
    
40. CATALANO OA, Bhan I, Asmundo L, Bradley WR, et al
    Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with Cirrhosis.
    J Nucl Med. 2025 Dec 30:jnumed.125.271228. doi: 10.2967/jnumed.125.271228.
    PubMed         Abstract available
    
    
41. SALERNO I, Dunn N, White H, Miyazaki W, et al
    Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications.
    J Nucl Med. 2025 Dec 30:jnumed.125.270987. doi: 10.2967/jnumed.125.270987.
    PubMed         Abstract available
    
    
42. MORRIS MJ, Hope TA, Sartor O
    Concepts in Phase 1 Radiopharmaceutical Therapy Trial Designs: Lessons from the SNMMI Dose Optimization in Radiopharmaceutical Therapy Development Workshop.
    J Nucl Med. 2025 Dec 30:jnumed.125.270792. doi: 10.2967/jnumed.125.270792.
    PubMed         Abstract available
    
    
43. SHEEHAN-KLENK J, Makala H, Chung JY, Lee W, et al
    Tetraspanin-8 as a Tumor-Selective Immuno-PET Target in Hepatocellular Carcinoma.
    J Nucl Med. 2025 Dec 30:jnumed.125.270594. doi: 10.2967/jnumed.125.270594.
    PubMed         Abstract available
    
    
44. CERCI JJ, Fanti S, Lobato EE, Kumar R, et al
    (68)Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, International IAEA Study.
    J Nucl Med. 2025 Nov 13:jnumed.125.270537. doi: 10.2967/jnumed.125.270537.
    PubMed         Abstract available
    
    
45. COOK BE, McLaren DG, Sullivan JM, El Fakhri G, et al
    Central Nervous System Biodistribution and Pharmacokinetics of Radiolabeled Tofersen in Rodents, Nonhuman Primates, and Humans.
    J Nucl Med. 2026;67:139-144.
    PubMed         Abstract available
    
    
46. ZHANG B, Long Y, Zhang Y, He Q, et al
    Ascorbic Acid Analog 6-Deoxy-6-(18)F-Fluoro-l-Ascorbic Acid PET Imaging of 23 Various Cancer Types.
    J Nucl Med. 2025 Dec 30:jnumed.125.270983. doi: 10.2967/jnumed.125.270983.
    PubMed         Abstract available
    
    
47. MOAR EF, Keilholz M, Sheikh GT, Werner RA, et al
    PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOG.
    J Nucl Med. 2025 Dec 30:jnumed.125.271324. doi: 10.2967/jnumed.125.271324.
    PubMed         Abstract available
    
    
48. LAZZERONI M, Ureba A, Schafer H, Nicolay NH, et al
    Biologically Individualized Radiotherapy Based on PET: A Novel Approach to Treatment Optimization of Head and Neck Cancer.
    J Nucl Med. 2025 Dec 30:jnumed.125.270403. doi: 10.2967/jnumed.125.270403.
    PubMed         Abstract available
    
    
49. ZHENG X, Zhang Y, Fang J, Li L, et al
    CD70-Targeted Immuno-PET/CT for Detecting Heterogeneous CD70 Expression in Lymphomas: A Pilot Clinical Study.
    J Nucl Med. 2025 Dec 30:jnumed.125.271097. doi: 10.2967/jnumed.125.271097.
    PubMed         Abstract available
    
    
50. DEXL J, Gatidis S, Fruh M, Jeblick K, et al
    AutoPET Challenge on Fully Automated Lesion Segmentation in Oncologic PET/CT Imaging, Part 2: Domain Generalization.
    J Nucl Med. 2025 Dec 30:jnumed.125.270260. doi: 10.2967/jnumed.125.270260.
    PubMed         Abstract available
    
    
51. 
    SPARC: Overarching Framework for PSMA PET Reporting.
    J Nucl Med. 2026;67:4A.
    PubMed        
    
    
52. ORTNER G, Hoderlein X, Barbato F, Beyersdorff D, et al
    The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer.
    J Nucl Med. 2025 Nov 6:jnumed.125.270667. doi: 10.2967/jnumed.125.270667.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

53. RUIZ-ORTIZ M, Esteban-Perez J, Gomez-Grande A, Martinez-Albero E, et al
    Motor band sign in (18)F-FDG PET/CT studies: a biomarker of degenerative upper motor neuron disease? A study of three cases and literature review.
    Neurologia (Engl Ed). 2025 Dec 25:501931. doi: 10.1016/j.nrleng.2025.501931.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

54. LAL H, Malik D, Singh A, Prasad R, et al
    Preoperative loco-regional assessment of prostate carcinoma using multi-parametric MRI and prostate-specific membrane antigen PET-computed tomography: correlation with histopathology.
    Nucl Med Commun. 2025 Dec 25. doi: 10.1097/MNM.0000000000002101.
    PubMed         Abstract available
    
    
55. YAMAGATA T, Haramiishi K, Fukuchi K
    Direct comparison of photomultiplier tube and silicon photomultiplier PET systems on measuring metabolic tumor volume: phantom studies.
    Nucl Med Commun. 2025 Dec 25. doi: 10.1097/MNM.0000000000002097.
    PubMed         Abstract available
    
    
56. LUE KH, Chen YH, Chu SC, Lin CB, et al
    Combining the prognostic values of entropy-based heterogeneity features from 18F-fluorodeoxyglucose PET and transmission computed tomography using machine learning in patients with lung adenocarcinoma undergoing curative surgery.
    Nucl Med Commun. 2025 Dec 25. doi: 10.1097/MNM.0000000000002098.
    PubMed         Abstract available
    
    

    
    PLoS One

57. STRIJDHORST A, Oostveen RF, Schilder MPA, Braat AJAT, et al
    The immune checkpoint inhibitor avelumab increases aortic inflammation on [18F]FDG PET/CT: A retrospective cohort study.
    PLoS One. 2025;20:e0339671.
    PubMed         Abstract available
    
    
58. TANG P, Chen X, Li P, Zhang L, et al
    Discovery of F-18 labeled repurposed CNS drugs by computational strategy for effective tau imaging and alzheimer's diagnosis.
    PLoS One. 2025;20:e0338901.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

59. CIVAN C, Karpinski MJ, Rahbar K, Fendler WP, et al
    The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects.
    Semin Nucl Med. 2025 Dec 25:S0001-2998(25)00181.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.